Elbasvir and grazoprevir


Elbasvir and grazoprevir

Drug updated on 11/13/2023

Dosage FormTablet (oral; elbasvir/grazoprevir: 50 mg/100 mg)
Drug ClassAntivirals
Ongoing and
Completed Studies


  • Indicated for treatment of chronic HCV genotype 1 or 4 infection in adult and pediatric patients 12 years of age and older or weighing at least 30 kg.
  • Indicated for use with ribavirin in certain patient populations.